Literature DB >> 2807539

An orally administered bacterial immunomodulator primes rabbit neutrophils for increased oxidative burst in response to opsonized zymosan.

A Helmberg1, G Böck, H Wolf, G Wick.   

Abstract

To assess the potential effect of an orally administered immunomodulator, consisting of a lysate of seven different bacteria, on polymorphonuclear leukocyte (PMN) function, rabbits were fed this preparation for five consecutive days via a gastric tube. On day 6, PMN were separated from peripheral blood and oxidative burst was triggered by opsonized zymosan or 12-O-tetradecanoylphorbol-13-acetate and quantitated on a single-cell basis. This study presents the extension of an existing flow cytometric method, leading to the possibility of quantitating single-cell oxidative burst triggered by particulate (instead of only soluble) stimuli. By this means, treated animals showed statistically significant increased oxidative burst reactions compared with the control group. The data provide evidence that oral application of a bacterial immunomodulator leads to a primed state in PMN for increased oxidative activity in response to a particulate stimulus. This offers the possibility that the beneficial effect of similar treatment in humans may in part be due to comparable mechanisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807539      PMCID: PMC259870          DOI: 10.1128/iai.57.11.3576-3580.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Both recombinant interleukin-1 (beta) and purified human monocyte interleukin-1 prime human neutrophils for increased oxidative activity and promote neutrophil spreading.

Authors:  G W Sullivan; H T Carper; J A Sullivan; T Murata; G L Mandell
Journal:  J Leukoc Biol       Date:  1989-05       Impact factor: 4.962

2.  Human toxic neutrophils. 3. Metabolic characteristics.

Authors:  C E McCall; L R DeChatelet; M R Cooper; C Shannon
Journal:  J Infect Dis       Date:  1973-01       Impact factor: 5.226

3.  Interaction between human neutrophils and zymosan particles: the role of opsonins and divalent cations.

Authors:  D Roos; A A Bot; M L van Schaik; M de Boer; M R Daha
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

4.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

5.  Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.

Authors:  M Parant; F Parant; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

6.  Measurement of chemiluminescence in freshly drawn human blood. II. Clinical application of zymosan-induced chemiluminescence.

Authors:  M Heberer; M Ernst; M Dürig; M Allgöwer; H Fischer
Journal:  Klin Wochenschr       Date:  1982-12-01

7.  Muramyl dipeptide increases tolerance to shock and bacterial challenge in mice.

Authors:  J R Ausobsky; W G Cheadle; B G Brosky; H C Polk
Journal:  Br J Surg       Date:  1984-02       Impact factor: 6.939

8.  Specific immune response in the respiratory tract after administration of an oral polyvalent bacterial vaccine.

Authors:  R L Clancy; A W Cripps; A J Husband; D Buckley
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.

Authors:  D A Bass; J W Parce; L R Dechatelet; P Szejda; M C Seeds; M Thomas
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

10.  Systemic tolerance and secretory immunity after oral immunization.

Authors:  S J Challacombe; T B Tomasi
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  2 in total

1.  Hypocholesterolemic and immunostimulatory effects of orally applied Enterococcus faecium M-74 in man.

Authors:  A Mikes; M Ferencík; E Jahnová; L Ebringer; I Ciznár
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

2.  Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens.

Authors:  C Ruedl; M Frühwirth; G Wick; H Wolf
Journal:  Clin Diagn Lab Immunol       Date:  1994-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.